View Post

TAK-Impact Study

In News by John Geddes

Takayasu Arteritis patients, and physicians treating them, are invited to take part in the TAK-IMPACT study (Investigating the Management, Perspectives, and Attitudes towards Care in Takayasu Arteritis). This is an anonymous questionnaire-based …

View Post

“My world has shrunk”

In News by John Geddes

“My world has shrunk” is the title of a mixed-methods exploration of the impact of systemic autoimmune rheumatic diseases on patients’ lives, which is the subject of an article in …

View Post

In News by John Geddes

RAIRDA have produced a newsletter giving an update on their recent work, including their comments on the government’s proposed 10-year Health Plan for England.

View Post

NICE Approves Benralizumab for EGPA Treatment

In News by John Geddes

The National Institute for Health and Care Excellence (NICE) has issued its final draft guidance recommending benralizumab as a treatment option for people with eosinophilic granulomatosis with polyangiitis (EGPA). This …

View Post

New Guidelines for ANCA Associated Vasculitis

In News by John Geddes

A group of experts from the British Society for Rheumatology came together to improve care for people ANCA-associated vasculitis. These experts included doctors who specialize in joints, kidneys, lungs, ear, …

View Post

AGM presentations

In News by John Geddes

The main slide deck from the 2025 AGM is now available (as a PDF file). The AGM included a presentation by Alice Muir, on the RECORDER project. The resultant set …

View Post

Visualising Vasculitis

In News by John Geddes

During May 2025, Vasculitis UK will share what it is like to live with Vasculitis, and we encourage people to hold an event on the 15th or 31st May (or …

View Post

Report: Rare Care Matters

In News by John Geddes

Almost one-third of UK rare rheumatic patients face a five-year wait for diagnosis Today, a new report reveals that some individuals with rare autoimmune rheumatic diseases (RAIRDs) in the UK …